Catecholamines can induce pulmonary remodeling in rats

Cellular Physiology and Biochemistry

Volumn 30, Issue 5, 2012, Pages 1134-1147

  Rassler, Beate ^a   Marx, Grit ^a   Schierle, Katrin ^b   Zimmer, Heinz Gerd ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Collagen; Isoproterenol; Matrix metalloproteinase 2; Norepinephrine; Phenylephrine; Pulmonary extracellular matrix; Pulmonary fbrosis; Transforming growth factor

Indexed keywords

CATECHOLAMINE; COLLAGEN TYPE 1; GELATINASE A; ISOPRENALINE; MESSENGER RNA; NORADRENALIN; PHENYLEPHRINE; SODIUM CHLORIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; LUNG DISEASE; LUNG FIBROSIS; LUNG HEMODYNAMICS; LUNG PARENCHYMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY REMODELING; RAT;

RATTUS;

ANIMALS; EXTRACELLULAR MATRIX; FEMALE; ISOPROTERENOL; MATRIX METALLOPROTEINASE 2; NOREPINEPHRINE; PHENYLEPHRINE; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA;

EID: 84869213997     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343304     Document Type: Article

References (49)

1. Dincer HE, Gangopadhyay N, Wang R, Uhal BD: Norepinephrine induces alveolar epithelial apoptosis mediated by alpha-, beta-, and angiotensin receptor activation. Am J Physiol Lung Cell Mol Physiol 2001;281:L624-L630.
2. Chen HI, Kao SJ, Wang D, Lee RP, Su CF: Acute respiratory distress syndrome. J Biomed Sci 2003;10:588-592.
3. Rassler B, Barth W, Zimmer HG: Transient pleural effusion in norepinephrine-stimulated rats. Basic Res Cardiol 2001;96:471-477. (Pubitemid 34071097)
4. Rassler B, Reissig C, Briest W, Tannapfel A, Zimmer HG: Catecholamine-induced pulmonary edema and pleural effusion in rats - alpha-and beta-adrenergic effects. Respir Physiol Neurobiol 2003;135:25-37. (Pubitemid 36437524)
5. Rassler B, Rohling MA, Reissig C, Briest W, Tannapfel A, Zimmer HG: Involvement of cytokines and inflammation in catecholamine-induced pulmonary injury in rats. Vascular Disease Prevention 2005;2:1-9. (Pubitemid 40767548)
6. Pugin J, Verghese G, Widmer MC, Matthay MA: The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 1999;27:304-312. (Pubitemid 29113539)
7. Marshall RP, Bellingan G, Webb S, Puddicombe A, Goldsack N, McAnulty RJ, Laurent GJ: Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 2000;162:1783-1788.
8. Bellingan GJ: The pulmonary physician in critical care - 6: The pathogenesis of ALI/ARDS. Thorax 2002;57:540-546. (Pubitemid 34627988)
9. Olman MA, White KE, Ware LB, Cross MT, Zhu S, Matthay MA: Microarray analysis indicates that pulmonary edema fluid from patients with acute lung injury mediates inflammation, mitogen gene expression, and fibroblast proliferation through bioactive interleukin-1. Chest 2002;121:69S-70S. (Pubitemid 34248348)
10. Delclaux C, D'Ortho MP, Delacourt C, Lebargy F, Brun-Buisson C, Brochard L, Lemaire F, Lafuma C, Harf A: Gelatinases in epithelial lining fluid of patients with adult respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 1997;272:L442-L451.
11. Torii K, Iida K, Miyazaki Y, Saga S, Kondoh Y, Taniguchi H, Taki F, Takagi K, Matsuyama M, Suzuki R: Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med 1997;155:43-46. (Pubitemid 27053139)
12. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990;6:121-125.
13. Sternlicht MD, Werb Z: How matrix metalloproteinases regulate cell behaviour. Annu Rev Cell Dev Biol 2001;17:463-516. (Pubitemid 33096184)
14. Hall MC, Young DA, Waters JG, Rowan AD, Chantry A, Edwards DR, Clark IM: The Comparative Role of Activator Protein 1 and Smad Factors in the Regulation of Timp-1 and MMP-1 Gene Expression by Transforming Growth Factor-β1. J Biol Chem 2003;278:10304-10313. (Pubitemid 36800292)
15. Martin-Chouly CA, Astier A, Jacob C, Pruniaux MP, Bertrand C, Lagente V: Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors. Life Sci 2004;75:823-840. (Pubitemid 38737420)
16. Eickelberg O, Köhler E, Reichenberger F, Bertschin S, Woodtli T, Erne P, Perruchoud AP, Roth M: Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-β1 and TGF-β3. Am J Physiol Lung Cell Mol Physiol 1999;276:L814-L824. (Pubitemid 29249635)
17. Coker RK, Laurent GJ, Jeffery PK, Du Bois RM, Black CM, McAnulty RJ: Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung. Thorax 2001;56:549-556. (Pubitemid 32588534)
18. Tsuruda T, Costello-Boerrigter LC, Burnett JC Jr: Matrix metalloproteinases: pathways of induction by bioactive molecules. Heart Fail Rev 2004;9:53-61. (Pubitemid 38196077)
19. Bhambi B, Eghbali M: Effect of norepinephrine on myocardial collagen gene expression and response of cardiac fibroblasts after norepinephrine treatment. Am J Pathol 1991;139:1131-1142.
20. Akiyama-Uchida Y, Ashizawa N, Ohtsuru A, Seto S, Tsukazaki T, Kikuchi H, Yamashita S, Yano K: Norepinephrine Enhances Fibrosis Mediated by TGF-β in Cardiac Fibroblasts. Hypertension 2002;40:148-154. (Pubitemid 34840090)
21. Briest W, Hölzl A, Rassler B, Deten A, Leicht M, Baba HA, Zimmer HG: Cardiac remodeling after long term norepinephrine treatment in rats. Cardiovasc Res 2001;52:265-273. (Pubitemid 33000403)
22. Irlbeck M, Zimmer HG: Functional responses of the left and right heart of diabetic rats to alpha-and betaadrenergic receptor stimulation. Diabetes Res Clin Pract 1996;31:S79-86. (Pubitemid 26258884)
23. Leicht M, Greipel N, Raßler B, Zimmer HG: Catecholamine-induced cardiac hypertrophy in rats is associated with the activation of p70S6 kinase and c-Jun. NH2-terminal kinase 2. Exp Clin Cardiol 2002;7:131-137. (Pubitemid 36167945)
24. Tyagi SC, Matsubara L, Weber KT: Direct extraction and estimation of collagenase (s) activity by zymography in microquantities of rat myocardium and uterus. Clin Biochem 1993;26:191-198. (Pubitemid 23164945)
25. Irlbeck M, Mühling O, Iwai T, Zimmer HG: Different response of the rat left and right heart to norepinephrine. Cardiovasc Res 1996;31:157-162. (Pubitemid 26093065)
26. Staub NC: New concepts about the pathophysiology of pulmonary edema. J Thorac Imaging 1988;3:8-14.
27. Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D, Chapman HA: Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 2006;103:13180-13185. (Pubitemid 44338936)
28. McAnulty RJ: Fibroblasts and myofibroblasts: their source, function and role in disease. Int J Biochem Cell Biol 2007;39:666-671. (Pubitemid 46366802)
29. Risinger GM, Updike DL, Bullen EC, Tomasek JJ, Howard EW: TGF-beta suppresses the upregulation of MMP-2 by vascular smooth muscle cells in response to PDGF-BB. Am J Physiol Cell Physiol 2010;298:C191-201.
30. Ye H, Cai PC, Zhou Q, Ma WL: Transforming growth factor-beta1 suppresses the up-regulation of matrix metalloproteinase-2 by lung fibroblasts in response to tumor necrosis factor-alpha. Wound Rep Reg 2011;19:392-399.
31. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, Heath JK: Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987;6:1899-1904.
32. Coker RK, Laurent GJ, Shahzeidi S, Lympany PA, Du Bois RM, Jeffery PK, McAnulty RJ: Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol 1997;150:981-991.
33. Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N: Localization of Matrix Metalloproteinases-1, -2, and -9 and Tissue Inhibitor of Metalloproteinase-2 in Interstitial Lung Diseases. Lab Invest 1998;78:687-698. (Pubitemid 28307326)
34. Pardo A, Barrios R, Maldonado V, Meléndez J, Pérez J, Ruiz V, Segura-Valdez L, Sznajder JI, Selman M: Gelatinases A and B Are Up-Regulated in Rat Lungs by Subacute Hyperoxia. Pathogenetic Implications. Am J Pathol 1998;153:833-844. (Pubitemid 28419036)
35. Corbel M, Boichot E, Lagente V: Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury. Braz J Med Biol Res 2000;33:749-754.
36. Corbel M, Belleguic C, Boichot E, Lagente V: Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell Biol Toxicol 2002;18:51-61. (Pubitemid 34269789)
37. Selman M, Ruiz V, Cabrera S, Segura L, Ramirez R, Barrios R, Pardo A: TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol 2000;279:562-574.
38. Pardo A, Selman M: Idiopathic pulmonary fibrosis: new insights in its pathogenesis. Int J Biochem Cell Biol 2002;34:1534-1538.
39. Lohi J, Lehti K, Valtanen H, Parks WC, Keski-Oja J: Structural analysis and promoter characterization of the human membrane-type matrix- metalloproteinase-1 (MT1-MMP) gene. Gene 2000;242:75-86. (Pubitemid 30065091)
40. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI: Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995;270:5331-5338.
41. Fligiel SE, Standiford T, Fligiel HM, Tashkin D, Strieter RM, Warner RL, Johnson KJ, Varani J: Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury. Hum Pathol 2006;37:422-430.
42. Lin WC, Lin CF, Chen CL, Chen CW, Lin YS: Prediction of outcome in patients with acute respiratory distress syndrome by bronchoalveolar lavage inflammatory mediators. Exp Biol Med 2010;235:57-65.
43. D'Ortho MP, Jarreau PH, Delacourt C, Macquin-Mavier I, Levame M, Pezet S, Harf A, Lafuma C: Matrix metalloproteinase and elastase activities in LPS-induced acute lung injury in guinea pigs. Am J Physiol 1994;266:L209-L216.
44. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT: Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990;67:1355-1364.
45. Briest W, Homagk L, Rassler B, Ziegelhöffer-Mihalovicová B, Meier H, Tannapfel A, Leiblein S, Saalbach A, Deten A, Zimmer HG: Norepinephrine-induced changes in cardiac transforming growth factor-beta isoform expression pattern of female and male rats. Hypertension 2004;44:410-418. (Pubitemid 39281488)
46. O'Callaghan CJ, Williams B: The regulation of human vascular smooth muscle extracellular matrix protein production by alpha-and beta-adrenoceptor stimulation. J Hypertens 2002;20:287-294. (Pubitemid 34913794)
47. Briest W, Hölzl A, Rassler B, Deten A, Baba HA, Zimmer HG: Significance of matrix metalloproteinases in norepinephrine-induced remodelling of rat hearts. Cardiovasc Res 2003;57:379-387. (Pubitemid 36144216)
48. Allard MF, De Venny MF, Doss LK, Grizzle WE, Bishop SP: Alterations in dietary sodium affect isoproterenolinduced cardiac hypertrophy. J Mol Cell Cardiol 1990;22:1135-1145. (Pubitemid 20378826)
49. Meier H, Bullinger J, Marx G, Deten A, Horn LC, Rassler B, Zimmer HG, Briest W: Crucial role of interleukin-6. in the development of norepinephrine-induced left ventricular remodeling in mice. Cell Physiol Biochem 2009;23:327-334.